{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:13:54Z","timestamp":1794406434682,"version":"4.9.0"},"edition-number":"4","reference-count":26,"publisher":"Cambridge University Press","isbn-type":[{"value":"9781139023986","type":"electronic"},{"value":"9780521766272","type":"print"}],"license":[{"start":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T00:00:00Z","timestamp":1323043200000},"content-version":"unspecified","delay-in-days":46,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,20]]},"DOI":"10.1017\/cbo9781139023986.037","type":"book-chapter","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T08:26:07Z","timestamp":1323851167000},"page":"405-409","source":"Crossref","is-referenced-by-count":0,"title":["Laquinimod to treat multiple sclerosis"],"prefix":"10.1017","author":[{"given":"Douglas R.","family":"Jeffery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","reference":[{"key":"9781139023986#c76627-5061_c76627-5097","unstructured":"14. Kaye J. Laquinimod does not result in prolongation of heart survival in a model of allogeneic heterotopic rat heart transplants. Study No.HeartTx\/Teva- LQ\/Jun 2006."},{"key":"9781139023986#c76627-5061_c76627-5106","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(02)00039-4"},{"key":"9781139023986#c76627-5061_c76627-5108","first-page":"S154","article-title":"48-week open safety study with a high dose oral laquinimod in MS patients (P587)","volume":"11","author":"Sandberg-Wollheim","year":"2005","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5104","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000154520.48391.69"},{"key":"9781139023986#c76627-5061_c76627-5100","article-title":"The effect of Laquinimod on Lymphocyte VLA-4 properties under shear flow conditions (P628)","volume":"15","author":"Hayardeny","year":"2009","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5092","article-title":"The effect of laquinimod on the distribution of monocyte subsets (P808)","volume":"15","author":"Birnberg","year":"2009","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5086","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(02)00015-1"},{"key":"9781139023986#c76627-5061_c76627-5098","article-title":"Axonal protection effect of laquinimod appears partially independent of its inhibitory effect on inflammation and demyelination in experimental autoimmune encephalomyelitis (P06.208)","volume":"74","author":"Wegner","year":"2010","journal-title":"Neurology"},{"key":"9781139023986#c76627-5061_c76627-5103","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002238"},{"key":"9781139023986#c76627-5061_c76627-5094","first-page":"A378","article-title":"Laquinimod inhibits MOG-induced experimental encephalomyelitis (EAE) in CD4+CD25+ regulatory T-cell depleted mice (P08.051)","volume":"72","author":"Tarcic","year":"2009","journal-title":"Neurology"},{"key":"9781139023986#c76627-5061_c76627-5093","article-title":"The immunoregulatory properties of laquinimod on human B-cells","volume":"74","author":"Nussbaum","year":"2010","journal-title":"Neurology"},{"key":"9781139023986#c76627-5061_c76627-5095","article-title":"The activation of microglia and macrophages is attenuated by laquinimod (P04.222)","volume":"74","author":"Wang","year":"2010","journal-title":"Neurology"},{"key":"9781139023986#c76627-5061_c76627-5089","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.11.023"},{"key":"9781139023986#c76627-5061_c76627-5102","doi-asserted-by":"publisher","DOI":"10.1080\/00498250500066329"},{"key":"9781139023986#c76627-5061_c76627-5090","article-title":"Down regulation of antigen presentation and inflammatory pathways by laquinimod in cultured peripheral blood mononuclear cells of untreated multiple sclerosis patients and healthy controls (P01.120)","volume":"72","author":"Sonis","year":"2009","journal-title":"Neurology"},{"key":"9781139023986#c76627-5061_c76627-5096","article-title":"Laquinimod induces up-regulation of neurotrophins in serum of patients with relapsing-remitting multiple sclerosis (P783)","volume":"15","author":"Linker","year":"2009","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60918-6"},{"key":"9781139023986#c76627-5061_c76627-5091","article-title":"Effect of laquinimod on the dendritic cell compartment (P01.113)","volume":"72","author":"Birnberg","year":"2009","journal-title":"Neurology"},{"key":"9781139023986#c76627-5061_c76627-5101","article-title":"Laquinimod ameliorates experimental autoimmune encephalomyelitis via BDNF-dependent mechanisms (P881)","volume":"16","author":"Thone","year":"2010","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5088","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.02.016"},{"key":"9781139023986#c76627-5061_c76627-5107","first-page":"S127","article-title":"Long-term open extension of oral laquinimod in patients with relapsing multiple sclerosis shows favourable safety and sustained low relapse rate and MRI activity (P443)","volume":"15","author":"Comi","year":"2009","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5109","article-title":"Baseline demographics of a placebo-controlled, double-blind, randomised study of oral laquinimod 0.6 mg in treating relapsing-remitting multiple sclerosis: the ALLEGRO study (P442)","volume":"15","author":"Comi","year":"2009","journal-title":"Mult Scler"},{"key":"9781139023986#c76627-5061_c76627-5099","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.02.010"},{"key":"9781139023986#c76627-5061_c76627-5087","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00225-4"},{"key":"9781139023986#c76627-5061_c76627-5085","doi-asserted-by":"publisher","DOI":"10.1021\/jm031044w"},{"key":"9781139023986#c76627-5061_c76627-5084","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.9.1726"}],"container-title":["Multiple Sclerosis Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/36D46BEA0B5D1E182F488EF613A401A5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T19:49:12Z","timestamp":1654976952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/9781139023986%23c76627-5061\/type\/book_part"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,20]]},"ISBN":["9781139023986","9780521766272"],"references-count":26,"URL":"https:\/\/doi.org\/10.1017\/cbo9781139023986.037","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1017\/cbo9781139023986","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2011,10,20]]}}}